Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study Of Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients

NCT00201383 is registered in ClinicalTrials.gov with National Health Research Institutes, Taiwan as lead sponsor.

NCT NCT00201383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00201383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study Of Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients
Lead sponsor
National Health Research Institutes, Taiwan
Phase
Phase 3
Overall status
Completed
Start date
October 31, 1999
Completion date
August 31, 2009
Enrollment
161
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral cavity, squamous cell carcinoma